Literature DB >> 10901741

The diagnosis and management of ductal carcinoma in-situ of the breast.

D P Winchester1, J M Jeske, R A Goldschmidt.   

Abstract

The widespread utilization of screening mammography has produced a shift in the stage of breast cancer at diagnosis in the US: Currently, 12% to 15% of newly diagnosed breast cancer cases annually are ductal carcinoma in-situ (DCIS). The diagnosis is made, in at least 90% of patients, with mammography. Only about 10% of patients will have a palpable mass. The accurate characterization and visualization of calcifications typically requires magnification of mammographic imaging. The morphology of the calcifications is generally considered to be the most important factor in differentiating benign from malignant formations. Round and uniform shapes are more likely to be benign, while linear and heterogeneous morphologies are associated with DCIS. Following a complete mammographic work-up, most suspicious lesions are potential candidates for a stereotactic core needle biopsy. Ten percent to 50% of patients initially diagnosed with atypical ductal hyperplasia by needle biopsy have subsequently been surgically diagnosed with cancer near the biopsy site. Due to this relatively high incidence of co-existent carcinoma, a needle biopsy diagnosis of atypical ductal hyperplasia necessitates subsequent surgical excision. The most important change in our thinking about DCIS was from a monolithic view, conceiving of DCIS as a single disease highly likely to invade if left untreated, to the realization that DCIS represents a non-obligate precursor with a variable risk of progression, depending on a combination of factors, such as histology, lesion, size, and margin status. In discussing treatment options, patients should understand that local recurrence following total mastectomy is rare and that this is the procedure of choice for disease that cannot be adequately encompassed with a breast-conserving approach. If the patient and her surgeon are in agreement about proceeding with a breast-conserving approach, there needs to be a clear understanding of the incidence and implications of local recurrence. In all such discussions with newly diagnosed patients, however, it is essential to emphasize the excellent prognosis with this disease, irrespective of the surgical approach.

Entities:  

Mesh:

Year:  2000        PMID: 10901741     DOI: 10.3322/canjclin.50.3.184

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  9 in total

Review 1.  An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens.

Authors:  E A Rakha; I O Ellis
Journal:  J Clin Pathol       Date:  2007-07-14       Impact factor: 3.411

2.  Young age is not associated with increased local recurrence for DCIS treated by breast-conserving surgery and radiation.

Authors:  Aruna Turaka; Gary M Freedman; Tianyu Li; Penny R Anderson; Ramona Swaby; Nicos Nicolaou; Lori Goldstein; Elin R Sigurdson; Richard J Bleicher
Journal:  J Surg Oncol       Date:  2009-07-01       Impact factor: 3.454

Review 3.  The role of the microenvironment in tumor growth and invasion.

Authors:  Yangjin Kim; Magdalena A Stolarska; Hans G Othmer
Journal:  Prog Biophys Mol Biol       Date:  2011-06-28       Impact factor: 3.667

4.  Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practice.

Authors:  M F Dillon; C M Quinn; E W McDermott; A O'Doherty; N O'Higgins; A D K Hill
Journal:  J Clin Pathol       Date:  2006-07       Impact factor: 3.411

5.  The role of socioeconomic status in adjustment after ductal carcinoma in situ.

Authors:  Janet S de Moor; Ann H Partridge; Eric P Winer; Jennifer Ligibel; Karen M Emmons
Journal:  Cancer       Date:  2010-03-01       Impact factor: 6.860

6.  A computational study of the development of epithelial acini: II. Necessary conditions for structure and lumen stability.

Authors:  Katarzyna A Rejniak; Alexander R A Anderson
Journal:  Bull Math Biol       Date:  2008-04-10       Impact factor: 1.758

7.  Duct Excision is Still Necessary to Rule out Breast Cancer in Patients Presenting with Spontaneous Bloodstained Nipple Discharge.

Authors:  R E Foulkes; G Heard; T Boyce; R Skyrme; P A Holland; C A Gateley
Journal:  Int J Breast Cancer       Date:  2011-09-06

8.  Discrimination of Breast Cancer with Microcalcifications on Mammography by Deep Learning.

Authors:  Jinhua Wang; Xi Yang; Hongmin Cai; Wanchang Tan; Cangzheng Jin; Li Li
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

9.  National Variations in the Work-Up, Investigation, and Surgical Management of Ductal Carcinoma In Situ of the Breast across Canadian Surgeons.

Authors:  Ryerson Seguin; Lashan Peiris
Journal:  Curr Oncol       Date:  2021-03-29       Impact factor: 3.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.